A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

Charite - Universitaetsmedizin Berlin (CCM), Berlin

University of Pittsburgh Department of Dermatology, Pittsburgh

Groupe Hospitalier La Rochelle - Re - Aunis, La Rochelle

Hopital Larrey CHU de Toulouse, Toulouse

Park Avenue Dermatology, Orange Park

Olympian Clinical Research, Tampa

Forcare Clinical Research Inc, Tampa

Olympian Clinical Research, Largo

Renstar Medical Research, Ocala

University of Alabama Birmingham, Birmingham

CHU Saint Etienne, Saint-Priest-en-Jarez

Ohio State University, Columbus

Katholisches Klinikum Bochum gGmbH, Bochum

Indiana Clinical Trial Center, Plainfield

Hamzavi Dermatology, Fort Gratiot

Polyclinique de Courlancy, Reims

Universitaetsmedizin Mainz, Mainz

Universitatsklinikum Frankfurt, Frankfurt

Great Lakes Clinical Trials, Chicago

Central Dermatology, St Louis

Klinikum Darmstadt GmbH - Hautklinik, Darmstadt

Universitaetsklinikum Heidelberg, Heidelberg

Hopital Charles Nicolle, Rouen

Progressive Clinical Research, San Antonio

Haut- und Laserzentrum Freising, Freising

Clinical Studies Group, Henderson

Universitaetsklinik Erlangen, Erlangen

Hopital Prive d'Antony, Antony

Oregon Medical Research Center, Portland

Tufts Medical Center, Boston

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Clinical Partners, LLC, Johnston

Dermatology Associates of Seattle, Seattle

Dr Wei Jing Loo Medicine Professional Corporation, London

Skin Centre for Dermatology, Peterborough

York Dermatology Clinic and Research Centre, Richmond Hill

Alliance Clinical Trials, Waterloo

Bispebjerg Hospital, København NV

Sjaellands University Hospital, Roskilde

CHU de Nice, Nice

Stadtisches Klinikum Dresden, Dresden

University Medical Center Groningen, Groningen

Radboudumc, Nijmegen

Erasmus Medisch Centrum, Rotterdam